Polaroid said on an interactive platform on November 3 that at present, the CoFS business is still in the early stages of commercialization and has not formed industrial batch sales, so the short-term impact on the company's revenue and profits is small.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.